Monday, July 13, 2026
RSS

Inside BCI

Brain-Computer Interface Industry News
Industry News Research Policy Opinion Market Moves
About Directory Glossary
Market Moves

The BCI category is broadening beyond motor restoration in 2026

Across the first half of 2026 and the first weeks of the second half, three US Food and Drug Administration Breakthrough Device Designations were granted to non-motor-indication BCI and neuromodulation devices, Cortigent's existing Breakthrough-designated visual cortical prosthesis programme disclosed a secondary stroke motor rehab arm, three first-in-human or investigational-device clinical milestones landed, and two significant peer-reviewed publications extended the field's clinical use case. The motor-restoration pipeline itself continued to expand in the same window. This is a synthesis piece on what the data pattern actually shows and does not show.

Jul 13, 2026 · 13 min read

Policy & Regulation

Beijing Tiantan Hospital seeds Xizang's first plateau BCI centre at Lhasa People's Hospital

Xinhua reported on 9 July 2026 that Xizang (Tibet Autonomous Region)'s first plateau brain-computer interface clinical application centre was inaugurated at Lhasa People's Hospital. A medical assistance team from Beijing Tiantan Hospital, Capital Medical University, introduced the non-invasive EEG-based BCI technology, which drives exoskeleton and robotic-arm actuators for motor rehabilitation. The centre sits within a six-year Tiantan-Lhasa department-support partnership dating to 2020, and targets cerebral haemorrhage, cerebral ischemia, TBI, spinal cord injury, and peripheral nerve injury indications.

Jul 10 · 6 min read

Market Moves

CNBC profiles BrainCo as the Hangzhou non-invasive BCI leader runs up to its Hong Kong IPO

CNBC published a video interview by China reporter Elaine Yu with Nyx He, Partner and Senior Vice President at BrainCo, on 10 July 2026. The interview lands six months after BrainCo confidentially filed for a Hong Kong Stock Exchange listing on 12 January 2026 with CICC and UBS Group AG as arrangers, and six months after the company closed a ¥2 billion (approximately US$286 million) financing round co-led by IDG Capital and Walden International on 8 January 2026. BrainCo is one of Hangzhou's Six Little Dragons alongside DeepSeek, Unitree Robotics, Game Science, DEEP Robotics, and Manycore Tech.

Jul 10 · 7 min read

Market Moves

Paradromics hires Verily's former head of clinical neurology as Chief Clinical Officer

Paradromics announced on 7 July 2026 that William J. Marks, Jr., MD, MS-HCM, has joined as Chief Clinical Officer, a role distinct from the Chief Medical Officer position held by neurosurgeon Stephen Ryu. Marks was Head of Clinical Neurology and Head of Clinical Science at Verily Life Sciences from 2016 to 2023, before co-founding Nexus NeuroTech Ventures, which wound down 31 March 2026. The hire lands three weeks after Paradromics' first-in-human Connexus BCI implant at University of Michigan Health on 17 June 2026.

Jul 7 · 6 min read

Policy & Regulation

Beijing names Changfazhan its first BCI incubation platform under the Future Industry programme

Beijing Municipal Bureau of Economy and Information Technology announced on 1 July 2026, with English release on 7 July, that the Changfazhan Brain Science and Brain-Computer Interface Incubation Platform in Changping district has been designated as one of seven newly recognised Future Industry Incubation Platforms, the first BCI-specific platform under that specific programme. Shanghai municipal science commission director Luo Dajin separately claimed on 6 July that Shanghai hosted nearly 60 per cent of China's BCI financing events, 40 per cent of the disclosed funding amount, and one-third of the country's BCI companies in the first half of 2026.

Jul 7 · 7 min read

Market Moves

Nia Therapeutics gets FDA Breakthrough Designation for a preclinical TBI memory implant

Nia Therapeutics, an Allston Massachusetts company co-founded in 2018 by University of Pennsylvania memory neuroscientist Michael Kahana and cognitive neuromodulation researcher Daniel Rizzuto, received FDA Breakthrough Device Designation on 13 March 2026 for its Smart Neurostimulation System (SNS), indicated for episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The SNS is a 60-channel wireless closed-loop cortical implant whose platform hardware was validated in a sheep study published in Brain Stimulation in December 2025. It is preclinical: no human implant yet, IDE application planned for 2026.

Jul 5 · 11 min read

Industry News

Neuralink performs its first transdural implant on a Canadian ALS patient

Sgt Lee Marten of the Vancouver Police Department received a Neuralink N1 implant at Toronto Western Hospital on 20 May 2026, becoming the first Canadian ALS patient in the CAN-PRIME trial and the first human anywhere to receive the implant via Neuralink's new transdural surgical technique that preserves the dura rather than cutting it open. The story was broken by CBC News and MobiHealthNews on 2 July 2026.

Jul 4 · 7 min read

Policy & Regulation

China's NMPA locks BCI device classification: every implant is Class III, one narrow Class II lane

China's National Medical Products Administration issued Announcement No. 24 (2026) on 29 June 2026, releasing final Guiding Principles for the Classification and Definition of Brain-Computer Interface Medical Device Products plus a companion Generic Naming Guidelines. Every invasive BCI is Class III. Non-invasive BCIs are Class III by default. Non-invasive stroke-motor rehabilitation devices are Class II only if they do not incorporate artificial intelligence.

Jul 4 · 8 min read

Market Moves

Gestala closes US$62 million Angel+ round for ultrasound BCI, opens Shanghai NeuroAI headquarters

Gestala (格式塔科技), a Chinese non-invasive ultrasound brain-computer interface company led by founder and CEO Phoenix Peng, announced on 3 July 2026 that it had closed a US$62 million Angel+ financing round and formally opened a Shanghai NeuroAI headquarters. The company is the third Chinese ultrasound BCI startup to disclose funding within ten days, alongside Sisen Technology (1 July 2026) and Huachao Shenkong.

Jul 3 · 5 min read